Gufic Biosciences Limited Stock price NSE India S.E.

Equities

GUFICBIO

INE742B01025

Pharmaceuticals

Market Closed - NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
282.5 INR -0.98% Intraday chart for Gufic Biosciences Limited -3.65% -10.73%
Sales 2022 7.79B 93.49M Sales 2023 6.91B 82.87M Capitalization 18.09B 217M
Net income 2022 958M 11.5M Net income 2023 797M 9.56M EV / Sales 2022 3.16 x
Net Debt 2022 528M 6.33M Net Debt 2023 3.06B 36.67M EV / Sales 2023 3.06 x
P/E ratio 2022
25.2 x
P/E ratio 2023
22.7 x
Employees 1,628
Yield 2022
0.04%
Yield 2023
0.05%
Free-Float 21.37%
More Fundamentals * Assessed data
Dynamic Chart
Gufic Biosciences Secures Patent in India MT
Transcript : Gufic Biosciences Limited, Q3 2024 Earnings Call, Feb 16, 2024
Gufic Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Gufic Biosciences Gets New Patent in India MT
Gufic Biosciences Forms New Pharmaceutical Subsidiary MT
Transcript : Gufic Biosciences Limited, Q2 2024 Earnings Call, Nov 17, 2023
Gufic Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Lumosa Therapeutics Co., Ltd. Approves the Exclusive Licensing Agreement with Gufic Biosciences for LT1001, A Long-Acting Analgesic Injection CI
Gufic Biosciences Limited announced that it has received INR 999.9 million in funding from Motilal Oswal Financial Services Limited CI
Gufic Biosciences Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, UAE CI
Gufic Biosciences Granted Patent for its Invention MT
Gufic Biosciences Gets Nod from Australian, Brazilian Regulators for Parecoxib Sodium Lyophilized Powder MT
Gufic Biosciences Limited Receives Approval of TGA, Australia and the National Health Surveillance Agency, Brazil for Parecoxib 40Mg Injection CI
Motilal Oswal Financial to Acquire 3% Stake in Gufic Biosciences for INR1 Billion MT
Gufic Biosciences Limited announced that it expects to receive INR 999.9 million in funding from Motilal Oswal Financial Services Limited CI
More news
1 day-0.98%
1 week-3.65%
Current month-10.33%
1 month-8.71%
3 months-10.78%
6 months-1.48%
Current year-10.73%
More quotes
1 week
281.00
Extreme 281
301.30
1 month
277.65
Extreme 277.65
325.85
Current year
277.65
Extreme 277.65
364.90
1 year
179.60
Extreme 179.6
364.90
3 years
101.00
Extreme 101
364.90
5 years
37.00
Extreme 37
364.90
10 years
5.05
Extreme 5.05
364.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 04-06-24
Chief Executive Officer - 99-08-30
Director of Finance/CFO - 18-10-28
Members of the board TitleAgeSince
Chief Executive Officer - 99-08-30
Chief Executive Officer 41 04-06-24
Director/Board Member 64 86-12-31
More insiders
Date Price Change Volume
24-03-28 282.5 -0.98% 85 594
24-03-27 285.3 -2.08% 131,244
24-03-26 291.4 -2.05% 80,552
24-03-22 297.4 +1.45% 53,869
24-03-21 293.2 +1.30% 96,122

Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT

More quotes
Gufic Biosciences Limited is an India-based company that is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates through the Pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.
More about the company
  1. Stock
  2. Equities
  3. Stock Gufic Biosciences Limited
  4. Stock Gufic Biosciences Limited - NSE India S.E.